BioSpace News Archive

Vyera Pharmaceuticals, LLC acknowledges the decision announced by the U.S. Federal Trade Commission and the New York State Office of the Attorney General to file a civil action against Vyera, its parent company, and certain former members of its management relating to Daraprim®, which is a prescription drug used in combination with sulfonamide for the treatment of toxoplasmosis.

EpiVax Oncology, Inc., a precision cancer immunotherapy company, today announced the appointment of Daniel Adams as Chairman of the Board of Directors.

Promex Industries, a biotech microelectronics manufacturer specializing in heterogeneous integration of key subsystems for medical, diagnostic and life sciences devices, announced its participation in this week’s technical workshop on Advanced Packaging of Medical Microelectronics

Ningbo NewBay Medical Technology Co., Ltd. announced that it has entered into a licensing agreement with Genentech, a member of the Roche Group, under which it has been granted the exclusive global rights to further develop and commercialize GDC-0570, a small molecule Pan-PIM inhibitor that is active against multiple myeloma and prostate cancer in preclinical models.

Application is being reviewed under FDA’s Real-Time Oncology Review pilot program

Agreements Contingent on FTC and European Commission Approval and Completion of AbbVie’s Pending Acquisition of Allergan